| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.tejnaksh.com | |
| Market Cap | 68.94 Cr. | |
| Enterprise Value(EV) | 71.69 Cr. | 2023-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 1.66 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 40.97 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 48.20 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 21.43 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 3.17 | Calculated using Price: 67.88 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.02 Cr. | 10,156,800 Shares |
| FaceValue | 10 | |
| About Tejnaksh Healthcare Ltd. | ||
| The company is an integrated healthcare delivery service provider, committed to delivering quality healthcare services to its patients in modern facilities. Its operations are divided across four key vertical streams in healthcare delivery, namely - “Pediatric Urologyâ€, “Adult Urology (Male, Female)â€, “Andrology and Sexual Dysfunction†and “Nephrology, Dialysis and Renal Transplantâ€. It offers a gamut of more than 65 healthcare services under these streams. A base of over 65 employees and consultants supports its healthcare facility network. The company's healthcare facilities use advanced technology and its doctors, nurses and other healthcare professionals follow treatment protocols that match international standards. A majority of its healthcare facilities provide secondary, tertiary and quaternary healthcare services to patients. Some of its healthcare facilities provide super speciality quaternary healthcare to patients in key specialty areas such as Pediatric Urology and Adult Urology (Male, Female). | ||
| 1 Day |
|
+2.24% |
| 1 Week |
|
-3.96% |
| 1 Month |
|
-7.03% |
| 3 Month |
|
-23.70% |
| 6 Month |
|
-43.78% |
| 1 Year |
|
-55.82% |
| 2 Year |
|
+11.46% |
| 5 Year |
|
-17.22% |
| 10 Year |
|
| 7 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 21.17 | 26.68 | 34.98 | 26.93 | 15.10 | 12.71 | 15.05 | |
| Return on Capital Employed (%) | 34.00 | 29.35 | 32.66 | 27.59 | 17.78 | 14.20 | 17.20 | |
| Return on Assets (%) | 19.32 | 16.96 | 17.97 | 14.93 | 9.10 | 8.36 | 10.38 |
| Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
| Shh. Funds | 6 | 8 | 10 | 13 | 15 | 17 | 20 | 22 | |
| Non Curr. Liab. | 0 | 7 | 6 | 6 | 7 | 5 | 7 | 7 | |
| Curr. Liab. | 0 | 1 | 3 | 2 | 2 | 2 | 2 | 2 | |
| Minority Int. | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||
| Equity & Liab. | 7 | 16 | 20 | 22 | 25 | 25 | 30 | 31 | |
| Non Curr. Assets | 6 | 14 | 17 | 18 | 18 | 21 | 25 | 25 | |
| Curr. Assets | 1 | 2 | 3 | 5 | 7 | 3 | 5 | 6 | |
| Misc. Exp. not W/O | |||||||||
| Total Assets | 7 | 16 | 20 | 22 | 25 | 25 | 30 | 31 |
| Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
| Net Sales | 5 | 7 | 14 | 20 | 17 | 12 | 13 | 12 | |
| Other Income | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | |
| Total Income | 5 | 7 | 15 | 21 | 17 | 12 | 13 | 12 | |
| Total Expenditure | -2 | -4 | -9 | -16 | -13 | -8 | -8 | -8 | |
| PBIDT | 2 | 3 | 6 | 6 | 4 | 4 | 5 | 4 | |
| Interest | 0 | -1 | -1 | -1 | -1 | 0 | -1 | ||
| Depreciation | 0 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | |
| Taxation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
| Exceptional Items | |||||||||
| PAT | 1 | 2 | 3 | 3 | 2 | 2 | 3 | 2 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Share Associate | 0 | ||||||||
| Other Related Items | |||||||||
| Consolidated Net Profit | 1 | 2 | 3 | 3 | 2 | 2 | 3 | 2 | |
| Adjusted EPS | 1 | 2 | 3 | 3 | 2 | 2 | 3 | 2 |
| Particulars | 7 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 4 | 2 | 4 | 3 | 1 | 1 | 9 | |
| Cash Fr. Inv. | -3 | -8 | -3 | -2 | -1 | 2 | -11 | |
| Cash Fr. Finan. | 0 | 6 | -1 | -2 | 0 | -3 | 2 | |
| Net Change | 0 | 1 | 1 | -1 | 0 | 0 | 0 | |
| Cash & Cash Eqvt | 0 | 1 | 2 | 1 | 1 | 1 | 1 |
|
Tue, 30 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance Pursuant to Regulation 24A of SEBI {Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8" February 2019; we are attaching herewith the Annual Secretarial Compliance Report of the Company for the year ended 31° March 2023 issued by NS Dave and Associates Practicing Company Secretary and Secretarial Auditor of the Company. |
|
Tue, 30 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication In compliance of provision of Regulation 47 read with Regulation 30 of the SEBI (LODR) Regulations 2015 the Company has published the Postal Ballot Notice.The Notice were published in Active Times (English Newspaper) and MumbaiLakshadweep (Marathi Newspaper) on May 26 2023. |
|
Wed, 24 May 2023
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot Submission of Postal Ballot Notice Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. |
| Thu, 01 Jun 2023 |
Close Crossing Last Month Close From Below
|
Close Below Last Week Low
|
High Decrease in 1 Month
|
High Decrease in 3 Months
|
High Decrease in 6 Months
|
Equities
M.F.
Sectors
StockEdge Social